{
    "medicine_id": "042f9814907f589a0cf70ed4b1fec9030a8ffc10",
    "platform_id": "DB05063",
    "metadata": {
        "name": "Arcapta Neohaler 75 ug 1 Capsule",
        "composition": "75 ug 1 Mitoquinone",
        "clinical_particulars": {
            "therapeutic_indications": "Investigated for use treatment in hepatitis viral C and parkinson s disease",
            "contraindications": {
                "disease": "NA",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Mitoquinone may help to prevent the nerve cell damage that leads to Parkinson s disease It aims to slow or halt Parkinson s disease at its cause by tackling cell damage caused when mitochondria cease to function normally It is anticipated that MitoQ will slow or arrest the progression of Parkinson s disease symptoms Hepatits C virus can directly alter mitochondrial function leading to increased reactive oxygen species free radical production that can lead to scarring of the liver and cirrhosis Mitoquinone could be used to halt or decrease liver inflammation and fibrosis progression even in the absence of sustained virologic response Mitoquinone directly affects the mitochondria in two steps a targeting component directs the drug to the mitochondria and an antioxidant component helps to prevent cell damage",
                "excipients": "NA",
                "incompatibilities": []
            }
        },
        "revision_date": "2023-05-14"
    }
}